e-learning
resources
ERJ
2004
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation
Nusair S., Breuer R., Shapira M.Y., Berkman N., Or R.
Source:
Eur Respir J 2004; 23: 440-445
Journal Issue:
March
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Nusair S., Breuer R., Shapira M.Y., Berkman N., Or R.. Low incidence of pulmonary complications following nonmyeloablative stem cell transplantation. Eur Respir J 2004; 23: 440-445
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Pirfenidone treatment in patients with bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
Source: International Congress 2016 – Orphan diseases II
Year: 2016
Updated prevalence and risk factors for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation.
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018
Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation
Source: Eur Respir J 2011; 38: 470-472
Year: 2011
Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008
Noninfectious pulmonary complications of haematopoietic stem cell transplantation
Source: Eur Respir Rev, 29 (156) 190119; 10.1183/16000617.0119-2019
Year: 2020
Bronchiolitis obliterans following haematopoietic stem cell transplantation
Source: Eur Respir J 2007; 29: 1007-1019
Year: 2007
Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
Source: Eur Respir J 2005; 25: 402-405
Year: 2005
Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study
Source: Eur Respir J 2005; 25: 490-493
Year: 2005
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Lung biopsy predicts outcome in bronchiolitis obliterans following allogeneic stemcell transplantation
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011
Late idiopathic pneumonia syndrome after hematopoietic bone marrow transplantation: prognosis remains poor despite the use of etanercept
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008
Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003
Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant
Source: Eur Respir J, 52 (1) 1702328; 10.1183/13993003.02328-2017
Year: 2018
Late pulmonary complications after haematopoietic stem cell transplantation (HSCT) in children: incidence and risk factors
Source: Annual Congress 2008 - Pulmonary infections in children - rare but important aspects
Year: 2008
Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation
Source: Eur Respir J, 51 (5) 1702617; 10.1183/13993003.02617-2017
Year: 2018
Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation
Source: Eur Respir J 2014; 43: 221-232
Year: 2004
Long term follow-up of patients with Bronchiolitis obliterans Syndrome after hematopoietic stem cell transplantation
Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans
Year: 2019
Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Does colonization with
pseudomonas
affects the prevalence of bronchiolitis obliterans syndrome after lung transplantation?
Source: Annual Congress 2006 - Dealing with chronic allograft dysfunction: mission impossible?
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept